Eli Lilly (LLY) has agreed to acquire Merida Biosciences for up to $2.875B in cash, including an upfront payment and ...
Eli Lilly and Company (LLY) said Monday that it agreed to acquire Merida Biosciences for up to $2.88 billion in cash, including upfront and milestone payments, to expand its pipel ...
Earnings call Eli Lilly reported Q4 2025 revenue growth of 43% YoY and full-year revenue of $65.2B (+45% YoY), with EPS up 86% to $24.21. 2026 guidance calls for $80–$83B in revenue (+25% YoY at ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
On August 17, OmniAb, Inc. (NASDAQ:OABI) announced a global collaboration and license agreement with Eli Lilly and Company ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results